• Users Online: 317
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2021| September-December  | Volume 5 | Issue 3  
    Online since December 14, 2021

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ORIGINAL ARTICLES
A Retrospective analysis of biosimilar and reference trastuzumab in human epidermal growth factor receptor-2 positive early and/or locally advanced breast cancer patients treated with neoadjuvant-adjuvant setting: Safety and event-free survival outcomes
Rahul Kulkarni, Shriniwas Kulkarni, Almas Pathan, Shona Nag
September-December 2021, 5(3):97-103
DOI:10.4103/oji.oji_25_21  
  486 36 -
Prevalence of breakthrough chemotherapy-induced nausea vomiting in patients on highly emetogenic chemotherapy: A Single-center observational study
Pooja P Lokkur, Neelakshi Mahanta, Naba Kumar Kalita, Hitesh Deka, Niharika Kutum, Arpita Ray
September-December 2021, 5(3):92-96
DOI:10.4103/oji.oji_22_21  
  417 44 -
Histomorphological spectrum of incidentally detected fallopian tube lesions in patients operated for various clinical conditions and detection of precursor lesion by applying sectioning and extensively examining the fimbriated end sampling protocol
Neha Singh, Ipsita Dhal, Aneesha Mohanpuria, Swati Saxena
September-December 2021, 5(3):85-91
DOI:10.4103/oji.oji_7_21  
  399 61 -
Epidemiological, clinical profile, and treatment outcome of stage iv nonsquamous nonsmall cell lung cancer patients presenting to tertiary care hospital in North India
Venkata Pradeep Babu Koyyala, Manish Sharma, Pankaj Goyal, Varun Goel, Sravya Bommera, Mohit Agrawal, Kshitiz Domadia, Krushna Choudhary, Sneha Bothra, Ankush Jajodia, BP Amrith, Srujana Joga, Sunil Pasricha, Ullas Batra
September-December 2021, 5(3):104-110
DOI:10.4103/oji.oji_34_21  
  282 34 -
Primary tracheal cancer: A regional cancer center experience
Pooja Babbar, AH Rudresha, D Lokanatha, Ravi Arjunan, Linu Jacob, M C Suresh Babu, KN Lokesh, LK Rajeev, Smith C Saldanha, GH Abhilash, Amit Pandey
September-December 2021, 5(3):111-115
DOI:10.4103/oji.oji_35_21  
  262 32 -
BRIEF COMMUNICATION
Indian subset analysis of a phase iiib open-label study of afatinib in epidermal growth factor receptor tyrosine kinase inhibitor-naïve patients with epidermal growth factor receptor mutation positive non-small cell lung cancer
Senthil J Rajappa, BJ Srinivasa, Shailesh A Bondarde, Partha Mohan Gokhale, Pankaj Sonone, Arun Kumar Dahiya
September-December 2021, 5(3):116-118
DOI:10.4103/oji.oji_40_21  
  200 21 -
CASE REPORTS
Ifosfamide induced encephalopathy: A rare case presentation and management with review of the literature
Namratha Sai Reddy Bijivemula, Nishith Vaddeboina, PS Dattatreya, A V S Suresh, Ch. Mohana Vamsy
September-December 2021, 5(3):123-125
DOI:10.4103/oji.oji_32_21  
  161 18 -
Primary ureteral mucinous adenocarcinoma with xanthogranulomatous pyelonephritis masquerading as a giant renal mass
Ajay Shyam Kanbur, Atul J Mokashi, Supriya Dutta, Aniket N Hase
September-December 2021, 5(3):119-122
DOI:10.4103/oji.oji_53_20  
  110 14 -